FindTrial
Sign In

Rationalizing use of antimetabolites in glaucoma surgery

Intraoperative versus delayed use of Mitomycin C in trabeculectomy: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013200
Enrollment
20
Registered
2018-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Advanced glaucoma requiring surgical intervention for intraocular pressure control Health Condition 2: H401- Open-angle glaucoma

Interventions

Intervention1: Mitomycin C application: Application of Mitomycin C during trabeculectomy Control Intervention1: Group 1: Intraoperative application of mitomycin C in dose of 0.02% Control Intervention

Sponsors

Postgraduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The advanced glaucoma patients attending the glaucoma clinic of a tertiary care Institute, requiring surgical intervention for IOP control were enrolled.

Exclusion criteria

Exclusion criteria: Patients with preexisting glaucoma surgery were excluded

Design outcomes

Primary

MeasureTime frame
The IOP trend and bleb morphologyTimepoint: postoperative day 1, day 7, 1 month, 3rd month, 6th month, 1 year and final follow up—

Secondary

MeasureTime frame
Requirement of antiglaucoma medication (agm)/surgeryTimepoint: postoperative day 1, day 7, 1 month, 3rd month, 6th month, 1 year and final follow up—

Countries

India

Contacts

Public ContactSurinder Singh Pandav

Postgraduate Institute of Medical Education and Research

sspandav@yahoo.com9876644007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026